These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25788044)

  • 61. I-131 MIBG post-therapy scan is more sensitive than I-123 MIBG pretherapy scan in the evaluation of metastatic neuroblastoma.
    Yang J; Codreanu I; Servaes S; Zhuang H
    Nucl Med Commun; 2012 Nov; 33(11):1134-7. PubMed ID: 22825037
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biodistribution of post-therapeutic versus diagnostic (131)I-MIBG scans in children with neuroblastoma.
    Hickeson MP; Charron M; Maris JM; Brophy P; Kang TI; Zhuang H; Khan J; Nevrotski T
    Pediatr Blood Cancer; 2004 Mar; 42(3):268-74. PubMed ID: 14752865
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97.
    Schmidt M; Simon T; Hero B; Schicha H; Berthold F
    Eur J Cancer; 2008 Jul; 44(11):1552-8. PubMed ID: 18424129
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Follow up control of stage IV neuroblastoma: 123I-MIBG scintigraphy, bone scintigraphy and catecholamine metabolites].
    Kohnert K; Lerch H; Thelen M; Jürgens H; Schober O
    Nuklearmedizin; 1996 Dec; 35(6):220-4. PubMed ID: 8999421
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Histological features of primary tumors after induction or high-dose chemotherapy in high-risk neuroblastoma.
    Hishiki T; Horie H; Higashimoto Y; Yotsumoto K; Komatsu S; Okimoto Y; Kakuda H; Taneyama Y; Saito T; Terui K; Mitsunaga T; Nakata M; Ochiai H; Hino M; Ando K; Yoshida H; Iwai J
    Pediatr Surg Int; 2014 Sep; 30(9):919-26. PubMed ID: 25064228
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Whole-Body Pediatric Neuroblastoma Imaging: 123I-mIBG and Beyond.
    Pai Panandiker AS; Coleman J; Shulkin B
    Clin Nucl Med; 2015 Sep; 40(9):737-9. PubMed ID: 26053707
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pitfalls in the interpretation of MIBG scans in cervical neuroblastoma.
    Yanchar NL; Chou S
    Pediatr Surg Int; 2000; 16(5-6):451-3. PubMed ID: 10955591
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.
    Matthay KK; Shulkin B; Ladenstein R; Michon J; Giammarile F; Lewington V; Pearson AD; Cohn SL
    Br J Cancer; 2010 Apr; 102(9):1319-26. PubMed ID: 20424613
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MIBG (metaiodobenzylguanidine) theranostics in pediatric and adult malignancies.
    Agrawal A; Rangarajan V; Shah S; Puranik A; Purandare N
    Br J Radiol; 2018 Nov; 91(1091):20180103. PubMed ID: 30048149
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Theranostics in Neuroblastoma.
    Rafael MS; Cohen-Gogo S; Irwin MS; Vali R; Shammas A; Morgenstern DA
    PET Clin; 2021 Jul; 16(3):419-427. PubMed ID: 34053585
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 123I-metaiodobenzylguanidine (MIBG)-positive testicular mass in a neuroblastoma.
    Harada A; Makimoto A; Shimojima N; Yuza Y; Hirobe S
    Pediatr Int; 2020 Dec; 62(12):1398-1399. PubMed ID: 33270314
    [No Abstract]   [Full Text] [Related]  

  • 72. Neuroblastoma maturation by [(131)I] metaiodobenzylguanidine in chemoresistant neuroblastoma.
    Ben Arush MW; Ben Itzhak O; Yossilevski G; El Hasid R; Postovsky S; Israel O
    Med Pediatr Oncol; 1999 Oct; 33(4):418-9. PubMed ID: 10491557
    [No Abstract]   [Full Text] [Related]  

  • 73. False-positive metaiodobenzylguanidine scan for neuroblastoma in a child with opsoclonus-myoclonus syndrome treated with adrenocorticotropic hormone (acth).
    McGarvey CK; Applegate K; Lee ND; Sokol DK
    J Child Neurol; 2006 Jul; 21(7):606-10. PubMed ID: 16970854
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Does a "false-negative" MIBG scan predict a better outcome in neuroblastoma patients?
    Garaventa A
    Med Pediatr Oncol; 2001 Oct; 37(4):418. PubMed ID: 11568913
    [No Abstract]   [Full Text] [Related]  

  • 75. [Intense uptake of 99mTc-MDP in primary abdominal neuroblastoma].
    Panoutsopoulos G; Ilias I; Parcharidou A; Christakopoulou I
    Rev Esp Med Nucl; 2002 Jul; 21(4):294-5. PubMed ID: 12206743
    [No Abstract]   [Full Text] [Related]  

  • 76. Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma.
    Feng L; Li S; Wang C; Yang J
    Semin Nucl Med; 2023 Jul; 53(4):517-529. PubMed ID: 36682980
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 131-I-metaiodobenzylguanidine and chemotherapy for advanced neuroblastoma.
    Mastrangelo S; Attinà G; Ruggiero A
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1325-1327. PubMed ID: 34311635
    [No Abstract]   [Full Text] [Related]  

  • 78. Pseudoneuroblastoma demonstrated by I-123 MIBG SPECT.
    Okuyama C; Ushijima Y; Nakamura T; Nishimura T
    Clin Nucl Med; 2001 May; 26(5):474-5. PubMed ID: 11317042
    [No Abstract]   [Full Text] [Related]  

  • 79. Neuroblastoma: management of a common childhood malignacy.
    Stebbins M
    JAAPA; 2010 Nov; 23(11):24-6, 51. PubMed ID: 21086886
    [No Abstract]   [Full Text] [Related]  

  • 80. Multi-modal 3-Dimensional Visualization of Pediatric Neuroblastoma: Aiding Surgical Planning Beyond Anatomical Information.
    Simons DC; Buser MAD; Fitski M; van de Ven CP; Ten Haken B; Wijnen MHWA; Tan CO; van der Steeg AFW
    J Pediatr Surg; 2024 Aug; 59(8):1575-1581. PubMed ID: 38461108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.